Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. Also, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan. more
Time Frame | RMTI | Sector | S&P500 |
---|---|---|---|
1-Week Return | 6.73% | -3.39% | 0.2% |
1-Month Return | -5.53% | -1.92% | 2.72% |
3-Month Return | -43.65% | -10.54% | 7.31% |
6-Month Return | 20.33% | -4.47% | 10.44% |
1-Year Return | 31.36% | 4.06% | 27.53% |
3-Year Return | -50.78% | 0.94% | 30.88% |
5-Year Return | -90.99% | 36.67% | 89.21% |
10-Year Return | -97.57% | 102.87% | 199.95% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 61.30M | 62.20M | 61.93M | 72.81M | 83.61M | [{"date":"2019-12-31","value":73.32,"profit":true},{"date":"2020-12-31","value":74.39,"profit":true},{"date":"2021-12-31","value":74.07,"profit":true},{"date":"2022-12-31","value":87.08,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 58.46M | 59.47M | 64.35M | 68.73M | 74.91M | [{"date":"2019-12-31","value":78.05,"profit":true},{"date":"2020-12-31","value":79.39,"profit":true},{"date":"2021-12-31","value":85.91,"profit":true},{"date":"2022-12-31","value":91.76,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 2.84M | 2.73M | (2.42M) | 4.08M | 8.70M | [{"date":"2019-12-31","value":32.62,"profit":true},{"date":"2020-12-31","value":31.31,"profit":true},{"date":"2021-12-31","value":-27.8,"profit":false},{"date":"2022-12-31","value":46.84,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 4.63% | 4.38% | (3.91%) | 5.60% | 10.41% | [{"date":"2019-12-31","value":44.49,"profit":true},{"date":"2020-12-31","value":42.09,"profit":true},{"date":"2021-12-31","value":-37.54,"profit":false},{"date":"2022-12-31","value":53.79,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Expenses | 36.93M | 31.14M | 27.92M | 20.86M | 15.37M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":84.33,"profit":true},{"date":"2021-12-31","value":75.58,"profit":true},{"date":"2022-12-31","value":56.47,"profit":true},{"date":"2023-12-31","value":41.63,"profit":true}] |
Operating Income | (34.10M) | (28.42M) | (30.34M) | (16.78M) | (6.67M) | [{"date":"2019-12-31","value":-3409529000,"profit":false},{"date":"2020-12-31","value":-2842000000,"profit":false},{"date":"2021-12-31","value":-3033600000,"profit":false},{"date":"2022-12-31","value":-1678000000,"profit":false},{"date":"2023-12-31","value":-667000000,"profit":false}] |
Total Non-Operating Income/Expense | 334.34K | (4.11M) | (4.68M) | (3.80M) | (3.19M) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-1229.6,"profit":false},{"date":"2021-12-31","value":-1398.59,"profit":false},{"date":"2022-12-31","value":-1137.18,"profit":false},{"date":"2023-12-31","value":-953.83,"profit":false}] |
Pre-Tax Income | (34.13M) | (30.89M) | (32.67M) | (18.68M) | (8.44M) | [{"date":"2019-12-31","value":-3412803100,"profit":false},{"date":"2020-12-31","value":-3089000000,"profit":false},{"date":"2021-12-31","value":-3267400000,"profit":false},{"date":"2022-12-31","value":-1867900000,"profit":false},{"date":"2023-12-31","value":-843900000,"profit":false}] |
Income Taxes | (3.05M) | 1.04M | 2.36M | 1.90M | 1.28M | [{"date":"2019-12-31","value":-129.24,"profit":false},{"date":"2020-12-31","value":44.15,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":80.47,"profit":true},{"date":"2023-12-31","value":54.07,"profit":true}] |
Income After Taxes | (31.08M) | (31.93M) | (35.03M) | (20.58M) | (9.72M) | [{"date":"2019-12-31","value":-3107805900,"profit":false},{"date":"2020-12-31","value":-3193200000,"profit":false},{"date":"2021-12-31","value":-3503400000,"profit":false},{"date":"2022-12-31","value":-2057800000,"profit":false},{"date":"2023-12-31","value":-971510500,"profit":false}] |
Income From Continuous Operations | (34.13M) | (30.89M) | (32.67M) | (18.68M) | (9.29M) | [{"date":"2019-12-31","value":-3412803100,"profit":false},{"date":"2020-12-31","value":-3089000000,"profit":false},{"date":"2021-12-31","value":-3267400000,"profit":false},{"date":"2022-12-31","value":-1867900000,"profit":false},{"date":"2023-12-31","value":-928900000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (31.08M) | (31.93M) | (35.03M) | (20.58M) | (8.44M) | [{"date":"2019-12-31","value":-3107805900,"profit":false},{"date":"2020-12-31","value":-3193200000,"profit":false},{"date":"2021-12-31","value":-3503400000,"profit":false},{"date":"2022-12-31","value":-2057800000,"profit":false},{"date":"2023-12-31","value":-843900000,"profit":false}] |
EPS (Diluted) | (6.16) | (4.40) | (2.84) | (1.25) | (0.40) | [{"date":"2019-12-31","value":-616,"profit":false},{"date":"2020-12-31","value":-440,"profit":false},{"date":"2021-12-31","value":-284,"profit":false},{"date":"2022-12-31","value":-125,"profit":false},{"date":"2023-12-31","value":-40,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
RMTI | |
---|---|
Cash Ratio | 1.29 |
Current Ratio | 2.41 |
Quick Ratio | 2.00 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
RMTI | |
---|---|
ROA (LTM) | -4.25% |
ROE (LTM) | -28.90% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
RMTI | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.49 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.51 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
RMTI | |
---|---|
Trailing PE | NM |
Forward PE | 59.17 |
P/S (TTM) | 0.76 |
P/B | 2.46 |
Price/FCF | 18 |
EV/R | 0.68 |
EV/Ebitda | 22.37 |
PEG | NM |
Rockwell Medical Inc (RMTI) share price today is $2.185
Yes, Indians can buy shares of Rockwell Medical Inc (RMTI) on Vested. To buy Rockwell Medical Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RMTI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Rockwell Medical Inc (RMTI) via the Vested app. You can start investing in Rockwell Medical Inc (RMTI) with a minimum investment of $1.
You can invest in shares of Rockwell Medical Inc (RMTI) via Vested in three simple steps:
The 52-week high price of Rockwell Medical Inc (RMTI) is $5.15. The 52-week low price of Rockwell Medical Inc (RMTI) is $1.16.
The price-to-earnings (P/E) ratio of Rockwell Medical Inc (RMTI) is
The price-to-book (P/B) ratio of Rockwell Medical Inc (RMTI) is 2.46
The dividend yield of Rockwell Medical Inc (RMTI) is 0.00%
The market capitalization of Rockwell Medical Inc (RMTI) is $71.75M
The stock symbol (or ticker) of Rockwell Medical Inc is RMTI